Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Eleanor C. Brockbank"'
Autor:
Andrew R Clamp, Mercedes Jimenez-Linan, Eleanor C Brockbank, Axel Walther, Marcia Hall, Rosalind Glasspool, Hani Gabra, Darren Ennis, Jon Stobo, Geoff Hall, Susan Freeman, Cheryl Wilson, Richard J. Edmondson, Ana Montes, Christina Fotopoulou, Iain A. McNeish, James Paul, Luisa Moore, Sudha Sundar, Teodora Goranova, Liz-Anne Lewsley, Geoff Macintyre, David Kay, Anna M. Piskorz, Charlie Gourley, Michelle Lockley, James D. Brenton
Publikováno v:
British Journal of Cancer
EurOPDX Consortium, Goranova, T, Ennis, D, Piskorz, A M, Macintyre, G, Lewsley, L A, Stobo, J, Wilson, C, Kay, D, Glasspool, R M, Lockley, M, Brockbank, E, Montes, A, Walther, A, Sundar, S, Edmondson, R, Hall, G D, Clamp, A, Gourley, C, Hall, M, Fotopoulou, C, Gabra, H, Freeman, S, Moore, L, Jimenez-Linan, M, Paul, J, Brenton, J D & McNeish, I A 2017, ' Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium ', British Journal of Cancer . https://doi.org/10.1038/bjc.2017.86
EurOPDX Consortium, Goranova, T, Ennis, D, Piskorz, A M, Macintyre, G, Lewsley, L A, Stobo, J, Wilson, C, Kay, D, Glasspool, R M, Lockley, M, Brockbank, E, Montes, A, Walther, A, Sundar, S, Edmondson, R, Hall, G D, Clamp, A, Gourley, C, Hall, M, Fotopoulou, C, Gabra, H, Freeman, S, Moore, L, Jimenez-Linan, M, Paul, J, Brenton, J D & McNeish, I A 2017, ' Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium ', British Journal of Cancer . https://doi.org/10.1038/bjc.2017.86
BACKGROUND: Investigating tumour evolution and acquired chemotherapy resistance requires analysis of sequential tumour material. We describe the feasibility of obtaining research biopsies in women with relapsed ovarian high-grade serous carcinoma (HG
Autor:
Paul A. Cohen, Aime Powell, Steffen Böhm, C. Blake Gilks, Colin J.R. Stewart, Tarek M. Meniawy, Max Bulsara, Stefanie Avril, Eleanor C. Brockbank, Tjalling Bosse, Gustavo Rubino de Azevedo Focchi, Raji Ganesan, Rosalind M. Glasspool, Brooke E. Howitt, Hyun-Soo Kim, Jung-Yun Lee, Nhu D. Le, Michelle Lockley, Ranjit Manchanda, Trupti Mandalia, W. Glenn McCluggage, Iain McNeish, Divya Midha, Radhika Srinivasan, Yun Yi Tan, Rachael van der Griend, Mayu Yunokawa, Gian F. Zannoni, Naveena Singh, Simi Aggarwal, Holger Bronger, Elizabeth B. Brown, Martin Buck, Syed A. Bukhari, Edwina Coghlan, Nichola Cope, Michelle Samora de Almeida, Cornelius D. De Kroon, Andrew Dean, Michael-John Devlin, Helena M. Ditzel, Enken Drecoll, Takahiro Ebata, Anna Fagotti, Asma Faruqi, Laura Feeney, Kavita Gupta, Ian Harley, Frediano Inzani, Arjun R. Jeyarajah, M.H. Eleanor Koay, Judith R. Kroep, Yee Leung, Alice R. Loft, Daniel MaGee, Sarah McKenna, David Millan, Joanne Millar, Rowan Miller, Ganendra R. Mohan, Sohail Mughal, Asima Mukhopadhyay, Sergio Mancini Nicolau, James Nevin, Abigail S. Oakley, Mary Quigley, Bhavana Rai, Arvind Rajwanshi, Stuart G. Salfinger, Giovanni Scambia, Kate Scatchard, Barbara Schmalfeldt, Bryony Simcock, Priya Singh, Kyle C. Strickland, Vainta Suri, Sheeba Syed, Peter Sykes, Kenji Tamura, Adeline Tan, Jason Tan, Emily Thompson, Anna V. Tinker, Georgia Trevisan, Maria Gabriela Baumgarten Kuster Uyeda, Michelle M. Vaughan, Wilko Weichert, Anthony Williams, Sarah Williams, Hiroshi Yoshida, Pier Carlo Zorzato
Publikováno v:
Cohen, P A, Powell, A, Böhm, S, Gilks, C B, Stewart, C J R, Meniawy, T M, Bulsara, M, Avril, S, Brockbank, E C, Bosse, T, de Azevedo Focchi, G R, Ganesan, R, Glasspool, R M, Howitt, B E, Kim, H S, Lee, J Y, Le, N D, Lockley, M, Manchanda, R, Mandalia, T, McCluggage, W G, McNeish, I, Midha, D, Srinivasan, R, Tan, Y Y, van der Griend, R, Yunokawa, M, Zannoni, G F, The HGSC CRS Collaborative Network (Supplementary 1) & Møgelbjerg Ditzel, H 2019, ' Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma : A systematic review and meta-analysis of individual patient data ', Gynecologic Oncology, vol. 154, no. 2, pp. 441-448 . https://doi.org/10.1016/j.ygyno.2019.04.679
Gynecologic Oncology, 154(2), 441-448. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic Oncology, 154(2), 441-448. ACADEMIC PRESS INC ELSEVIER SCIENCE
Objective. There is a need to develop and validate biomarkers for treatment response and survival in tubo-ovarian high-grade serous carcinoma (HGSC). The chemotherapy response score (CRS) stratifies patients into complete/near-complete (CRS3), partia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00a0a3d918f62859dca88e8d5a6e292c
https://findresearcher.sdu.dk:8443/ws/files/174798070/PIIS0090825819311813.pdf
https://findresearcher.sdu.dk:8443/ws/files/174798070/PIIS0090825819311813.pdf
Autor:
Michelle Lockley, Eleanor C Brockbank, Simone Tam, Arjun Jeyarajah, Martin Köbel, Rajeev Prasad, C. Blake Gilks, Steffen Böhm, Asma Faruqi, Naveena Singh, Laura Casey, Raji Ganesan
Publikováno v:
Histopathology. 71(5)
Aims The treatment of patients with tubo-ovarian high-grade serous carcinoma (HGSC) is increasingly based on diagnosis on small biopsy samples, and the first surgical sample is often taken post-chemotherapy. p53 and WT1 are important diagnostic marke